HomeNewsBusinessBusiness plans need re-boot amid coronavirus pandemic

Business plans need re-boot amid coronavirus pandemic

As the uncertainty and ambiguity around the COVID-19 scare stretches far out into the following quarters, here is a checklist of things to do for finance heads.

April 06, 2020 / 15:17 IST
Story continues below Advertisement

Sanjeev Jha

Globally, one-third nations are under a lockdown of some kind, bringing economic activities almost to a halt. Only essential services as recognised by governments are operating and businesses worldwide have been impacted, depending on what they deal in. Although no-one was prepared for the alarming speed at which the coronavirus pandemic hit us, it is time to act now and take proactive measures.

Story continues below Advertisement

Finance leaders in companies all over the world have been galvanised into action to prepare for this challenge that no one had foreseen.

According to various survey findings, just the period between the first week and the end of March has changed the opinion of many CFOs. While most of were not sure of the impact on their business when questioned at the beginning of March, by the end almost 60-80 percent saw a serious potential impact and started working on the plan for their business due to the lockdowns imposed in response to the pandemic.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show